Otsuka Pharmaceutical has signed a definitive arrangement agreement to acquire M...
Twist and Ono will discover and develop novel antibodies to treat autoimmune dis...
The $15m acquisition would give Zerva rights to Acer’s FDA-approved rare Urea cy...
The company announced a strategic shake-up that includes layoffs, leadership cha...
NexImmune will reduce its workforce from 47 to just 22 full-time employees and h...
Bayer adds three new Phase III heart failure studies to the Kidney and type 2 di...
Novo Nordisk's obesity drugs are driving Danish growth as well as record profits...
As per GlobalData, AbbVie has remained the Crohn’s disease market leader over th...
Reset Pharma has entered a licensing agreement with Filament for psilocybin drug...
Huadong has entered into an agreement to acquire licence rights for MC2 Therapeu...
In the latest edition of STAT's Health Tech newsletter: Biofourmis turmoil, Alex...
Though still in mouse experiments, a new, precise gene editing trick could lead ...
Stanford’s now ex-president Marc Tessier-Lavigne retracted two studies published...
The patients who took psilocybin experienced reduced depressive symptoms, an eff...
Large clinical trials are now testing amyloid-clearing drugs in people without s...
Layoffs in the U.S. pharmaceutical industry dipped in August, but the total for ...
